Ryan H. Moy, MD, PhD
Ryan H. Moy, MD, PhD

Ryan H. Moy, MD, PhD

Medical Oncology
phone icon
phone icon
Specialties
Medical Oncology, more

Locations and Appointments


New Patients
Virtual Visits
Call to ScheduleNew and Existing Patients
Existing Patients
Login or sign-up to Connect Patient Portal to make an appointment
Existing Patients
Login to Connect Patient Portal make an appointment, view documentation or contact your doctor’s office.
NYP Connect App
The NYP Connect App allows you to access convenient services to help manage your health. Access the patient portal, communicate with your doctor, manage appointments, view test results, request prescription refills, pay a bill, and find a doctor.

insurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • AETNA
  • Affinity Health Plan
  • AgeWell
  • Amerigroup of New Jersey
  • CIGNA
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Quality Health Management
  • RiverSpring
  • UnitedHealthcare
  • VNSNY CHOICE
  • WellCare
  • World Trade Center Health Plan

about icon
About Ryan H. Moy, MD, PhD

Dr. Ryan Moy is an Assistant Professor of Medicine and medical oncologist at Columbia University Irving Medical Center where he specializes in the treatment of gastrointestinal malignancies, with a focus on esophageal and stomach cancers. He received his MD/PhD from the University of Pennsylvania and completed internship and residency training in Internal Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. He then completed fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center and postdoctoral research at The Rockefeller University.


Dr. Moy is actively involved in translational research to understand the biological mechanisms that regulate metastasis, the primary driver of mortality in gastrointestinal cancers. He has performed laboratory-based research to define critical genes that promote liver metastasis in colorectal cancer. He is also conducting research to discover key vulnerabilities in esophageal and gastric cancers, with the goal of translating these findings from the lab to develop more effective treatments for patients. As an active member of the gastrointestinal oncology and experimental therapeutics groups, Dr. Moy is involved in developing and leading clinical trials investigating novel targeted and immunotherapy treatments for esophagogastric cancer and other malignancies. His work has been recognized by several awards including a Damon Runyon Cancer Research Foundation Fellow Award and a National Cancer Institute (NCI) K08 Career Development Award.


Dr. Moy works as part of a multidisciplinary team with the mission of delivering compassionate and state-of-the-art oncologic care to each patient, using a precision medicine approach to provide innovative and promising treatments.


list icon

Expertise

  • Esophageal Cancer

  • Gastrointestinal Malignancy

  • Liver Cancer

  • Stomach Cancer

list icon

Titles & Positions

  • Assistant Professor of Medicine at CUMC

list icon

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Titles & Positions

  • Assistant Professor of Medicine at CUMC